BFM
HELP

Boothbay Fund Management’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Boothbay Fund Management’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$194K Hold
29,404
– – ﹤0.01% 1942
2026
Q1 		$141K Hold
29,404
– – ﹤0.01% 1832
2025
Q4 		$241K Sell
29,404
-8,322
-22% -$53.6K ﹤0.01% 1575
2025
Q3 		$222K Hold
37,726
– – ﹤0.01% 1607
2025
Q2 		$317K Sell
37,726
-68,939
-65% -$501K 0.01% 1079
2025
Q1 		$676K Hold
106,665
– – 0.02% 758
2024
Q4 		$941K Buy
106,665
+9,029
+9% +$91.7K 0.02% 660
2024
Q3 		$868K Sell
97,636
-13,440
-12% -$133K 0.02% 797
2024
Q2 		$1.14M Hold
111,076
– – 0.03% 673
2024
Q1 		$1.75M Buy
+111,076
New +$1.6M 0.03% 552

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Boothbay Fund Management's HELP Position: Q2 2026 in Review

Boothbay Fund Management held its Helus Pharma Inc. Common Stock (HELP) position steady in Q2 2026 at 29,404 shares worth $194K. The position accounts for ﹤0.01% of the portfolio, ranked #1942.

Boothbay Fund Management first reported a position in HELP in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.75M in Q1 2024. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Boothbay Fund Management held 29,404 shares of Helus Pharma Inc. Common Stock worth $194K as of Q2 2026.
  • Boothbay Fund Management left its Helus Pharma Inc. Common Stock share count unchanged in Q2 2026.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1942 holding.
  • Boothbay Fund Management first reported a position in Helus Pharma Inc. Common Stock in Q1 2024 and has held it in 10 quarters since.
  • Boothbay Fund Management's Helus Pharma Inc. Common Stock position peaked at $1.75M in Q1 2024.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.